In fact, when CD8+ T cells were primed with B cells that were activated with αCD40, there was no effect on tumor growth and was similar to the untreated group, whereas there was modest treatment effect using CD8+ T cells primed with B cells activated by CD40L. The gene discussed is CD40LG; the disease is neoplasm.